Invesco, LLC Amgen Inc Transaction History

Invesco, LLC

$251 Billion
Q3 2024

A detailed history of Invesco, LLC transactions in Amgen Inc stock. As of the latest transaction made, Invesco, LLC holds 11,389 shares of AMGN stock, worth $3 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

11,389

Previous 11,380 0.08%

Holding current value

$3 Million

Previous $3.56 Billion 3.21%

% of portfolio

1.46%

Previous 1.49%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $2,784 - $3,036	9 Added 0.08%	11,389 $3.67 Billion
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $1,344 - $1,622	-5 Reduced 0.04%	11,380 $3.24 Billion
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $255 - $288	-1 Reduced 0.01%	11,385 $3.28 Billion
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $8,746 - $10,858	-40 Reduced 0.35%	11,386 $3.06 Billion
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $2.45 Million - $2.9 Million	11,426 New	11,426 $2.54 Billion

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.

Account